Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease.
Lipoxins are lipoxygenase-derived lipid mediators with both anti-inflammatory and proresolution properties that have been demonstrated in vivo and in vitro. The bioactivity profile of lipoxins in vitro suggests that they have therapeutic potential in acute renal failure and glomerulonephritis; predictions that have been borne out to date in experimental models of renal disease. We review recent developments on the molecular basis of lipoxin bioactions mediated through receptor crosstalk and the accumulating evidence that lipoxins may have potential as novel anti-inflammatory agents.
Kieran
Niamh E
NE
Department of Medicine and Therapeutics, Mater Misericordiae University Hospital, Dublin, Ireland.
Maderna
Paola
P
Godson
Catherine
C
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000378:metabolism* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy; D003872:Dermatitis / Q000188:drug therapy; D005355:Fibrosis; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology*; D044045:Lipoxins / Q000378:metabolism* / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D044045:Lipoxins